![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Report Second Quarter 2013 Financial Results
July 25, 2013 08:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., July 25, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Announces Completion of Enrollment in TRUST-I Phase 2 Clinical Trial of TSO for Crohn's Disease
July 01, 2013 07:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., July 1, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Participate in Upcoming Healthcare Investor Conferences
June 21, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., June 21, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Appoints George Avgerinos, Ph.D. as Senior Vice President, Biologics Operations
June 04, 2013 16:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., June 4, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the Jefferies 2013 Global Healthcare Conference
May 28, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 28, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2013
May 08, 2013 07:18 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
May 07, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 06, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 6, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Report First Quarter 2013 Financial Results
May 01, 2013 08:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Announces Departure of Dr. Bobby W. Sandage, Jr.
April 24, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., April 24, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...